Pyxis Oncology, Inc. - PYXS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | Prin Fin & Acct Officer | A | A | 262,635.0 | 0.0 | 0.0 | 262,635.0 | View | |
| Mar 25, 2026 | Prin Fin & Acct Officer | A | A | 109,461.0 | 0.0 | 0.0 | 512,882.0 | View | |
| Mar 25, 2026 | — | A | A | 45,867.0 | 0.0 | 0.0 | 45,867.0 | View | |
| Mar 25, 2026 | — | A | A | 45,867.0 | 0.0 | 0.0 | 45,867.0 | View | |
| Mar 25, 2026 | — | A | A | 45,867.0 | 0.0 | 0.0 | 45,867.0 | View | |
| Mar 25, 2026 | — | A | A | 45,867.0 | 0.0 | 0.0 | 45,867.0 | View | |
| Mar 25, 2026 | — | A | A | 45,867.0 | 0.0 | 0.0 | 45,867.0 | View | |
| Mar 25, 2026 | — | A | A | 45,867.0 | 0.0 | 0.0 | 45,867.0 | View | |
| Mar 25, 2026 | — | A | A | 45,867.0 | 0.0 | 0.0 | 45,867.0 | View | |
| Mar 25, 2026 | — | S | D | 13,896.0 | 1.0335 | 14,361.52 | 81,309.0 | View | |
| Mar 25, 2026 | — | S | D | 200.0 | 0.97 | 194.0 | 95,205.0 | View | |
| Mar 25, 2026 | — | S | D | 1,400.0 | 0.9727 | 1,361.78 | 95,405.0 | View | |
| Feb 05, 2026 | Interim CEO | A | A | 690,131.0 | 0.0 | 0.0 | 690,131.0 | View |